France · Biotechnology startup
France · Calida Therapeutics
Calida Therapeutics operates as a biotechnology company.
Funding reportedLast round: Post ipo equity
What company datasets say Calida Therapeutics raised
Funding, as reported
Reported in all66.5Min the source's currency
Rounds9
Last roundPost ipo equity
Last round dateMay 2024
Investors listed5
Founders and team
From Calida Therapeutics's own website: 4 on the team.
- Andrew JacksonChief Financial Officer
- Alan StewartBoard Member, Appointed October 2023
- James A. SchoeneckBoard Of Directors
- Scott LeftwichVice-Chairman of the Board, Appointed May 2019
On a portfolio page
Investors who name them
Each firm lists Calida Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in France
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Calida Therapeutics in front of investors. Or tell us what we have wrong.